FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
03/19/2026
Back to search
Official data from USPTO
LILIUMX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
03/20/2026
Trademark type
Word
Nice classes
42
Filing date
03/05/2024
Registration date
08/19/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/19/2025
Last transaction
03/20/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
98
Owner location
US
Examiner
SPILS, CAROL A
Law office
L40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Valink Therapeutics Inc.
Representatives
Matthew A. Homyk Blank Rome LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Scientific and technological services and research and design relating thereto in the field of medicine; scientific research for medical purposes; research and development of vaccines and medicines; scientific research for medical purposes in the area of cancerous diseases; research and development services in the field of antibodies; drug discovery services; pharmaceutical drug development services; pharmaceutical products development; development of pharmaceutical preparations and medicines; pharmaceutical research and development; conducting clinical trials for pharmaceutical products; testing of pharmaceuticals; biochemistry drug discovery services; scientific laboratory services; medical research laboratory services; consultancy in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/02/2026
FIMP
FINAL DISPOSITION PROCESSED
03/02/2026
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/30/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/19/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
11/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
11/12/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/19/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
08/19/2025
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
07/04/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/01/2025
PUBO
PUBLISHED FOR OPPOSITION
07/01/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/25/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/30/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
05/30/2025
ALIE
ASSIGNED TO LIE
05/30/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
05/29/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
05/29/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
05/29/2025
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/16/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/22/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2025
RFNT
REFUSAL PROCESSED BY IB
11/09/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/22/2024
RFRR
REFUSAL PROCESSED BY MPU
10/22/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/15/2024
CNRT
NON-FINAL ACTION WRITTEN
10/12/2024
DOCK
ASSIGNED TO EXAMINER
09/18/2024
MAFR
APPLICATION FILING RECEIPT MAILED
06/20/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/20/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/13/2024
Continuous trademark protection
Get notified about every new filing that threatens LILIUMX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.